Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy
about
A paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapyRETRACTED: Gene-gene interaction network analysis of ovarian cancer using TCGA dataTumor imaging and targeting potential of an Hsp70-derived 14-mer peptide.Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis updatePeptides and peptidomimetics as immunomodulators.Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivoAssociation of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population.Inhibition of cell adhesion and immune responses in the mouse model of collagen-induced arthritis with a peptidomimetic that blocks CD2-CD58 interface interactions.Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in miceClinical applications of mouse models for breast cancer engaging HER2/neu.Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers.Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.Targeted therapies in breast cancer: New challenges to fight against resistance.A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides.Molecular property diagnostic suite (MPDS): Development of disease-specific open source web portals for drug discovery.Bridging oncology and immunology: expanding horizons with innovative peptide vaccines and peptidomimetics.Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications.Combined immunotherapy of breast cancer with EGF and VEGF vaccines from DNA shuffling in a mouse model.
P2860
Q26824462-10184C1D-2984-4738-9325-49F816B19C59Q28386402-CC5DB8FC-7274-4952-9570-E128DECB6FC1Q34104760-9B90E53C-1451-4AC7-A8D5-29FC577C556FQ34265586-F78FF2A4-4865-4D16-B3A3-8F13C405E241Q34359984-4E51F7EA-BC3C-4D23-BB03-F6F4419B31F8Q35073267-13ABDA88-A8E0-4604-8E88-1EF2E097EAEEQ36266505-B6A3B355-2A5C-4227-B119-A0880A5D4CE1Q36338863-A31D479C-6307-4808-BE10-1D46650629B3Q37000178-AB262158-F9FD-419F-B3C8-0EEADF892061Q37607675-7502987C-A95E-432C-9B05-03886F4ABE02Q37671783-0B2808CA-D164-414D-B1BA-C6CC1110C3E8Q37705932-F4D33B75-6966-47E6-A6A7-99981FF9117EQ37743048-9A803FDE-7B54-4505-9E47-EBA296CC9C40Q38099265-7910009D-BA8E-4646-99FB-98737832B728Q40593958-AB4A6CCC-8EA2-43DF-A2EC-3BD17424819CQ42107855-2EED4DAA-1A81-4B5B-8748-6CBA35B69909Q47366650-DA31C29C-865B-4B64-8799-08E7E90EE7D6Q48140622-3C40E4D7-F9F1-4D96-B952-F67640687181Q49343443-FD82AF19-867C-4027-A9F9-29F4AF76D22BQ55000389-9FAA91F9-E60A-4CEC-B75E-B0CB06474044
P2860
Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Peptide vaccines and targeting ...... radigm in cancer immunotherapy
@ast
Peptide vaccines and targeting ...... radigm in cancer immunotherapy
@en
type
label
Peptide vaccines and targeting ...... radigm in cancer immunotherapy
@ast
Peptide vaccines and targeting ...... radigm in cancer immunotherapy
@en
prefLabel
Peptide vaccines and targeting ...... radigm in cancer immunotherapy
@ast
Peptide vaccines and targeting ...... radigm in cancer immunotherapy
@en
P2860
P356
P1433
P1476
Peptide vaccines and targeting ...... radigm in cancer immunotherapy
@en
P2093
Kevin Chu Foy
Pravin T P Kaumaya
P2860
P304
P356
10.2217/FON.12.95
P407
P577
2012-08-01T00:00:00Z